HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$11.20
Day range
$10.67 - $11.29
Year range
$6.15 - $739.20
Market cap
8.92M USD
Avg Volume
16.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.22M | -17.46% |
Net income | -4.28M | 17.61% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.21M | 17.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.37M | 119.85% |
Total assets | 8.27M | 71.34% |
Total liabilities | 2.12M | -39.51% |
Total equity | 6.15M | — |
Shares outstanding | 833.68K | — |
Price to book | 1.52 | — |
Return on assets | -98.35% | — |
Return on capital | -128.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.28M | 17.61% |
Cash from operations | -4.19M | -79.26% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -4.19M | -169.02% |
Free cash flow | -2.83M | -1,077.31% |
About
Founded
2016
Headquarters
Website
Employees
7
